Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Human IgG1 (K214R) kappa-Deruxtecan, ADC Control (DAR 8)

Copy Product Info
🥰Excellent

Synonyms:

Catalog No. T9901A-2044 Copy Product Info
🥰Excellent
Human IgG1 (K214R) kappa-Deruxtecan, ADC Control (DAR 8) is an IgG1-based antibody-drug conjugate control containing Deruxtecan (DXd) with an average DAR of 8. It can be used as a control in ADC.
Human IgG1
(K214R) kappa-Deruxtecan, ADC Control
(DAR 8)
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$83535 days35 days
5 mg$1,87035 days35 days
10 mgPreferential35 days35 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Human IgG1 (K214R) kappa-Deruxtecan, ADC Control (DAR 8) is an IgG1-based antibody-drug conjugate control containing Deruxtecan (DXd) with an average DAR of 8. It can be used as a control in ADC.
Reactivity
Human
Application
Functional assay
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Deruxtecan
Chemical Properties
Antibody Information
IsotypeHuman IgG1(K214R) kappa
Storage & Solubility Information
StorageStore at 4°C Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: